PSUSA/00000562/202506
Submitted by Anonymous (not verified) on 15 January 2026 - 15:02
PSUSA/00000562/202506
PSUSA/00001294/202506
Submitted by Anonymous (not verified) on 15 January 2026 - 15:00
PSUSA/00001294/202506
PSUSA/00000492/202506
Submitted by Anonymous (not verified) on 15 January 2026 - 14:55
PSUSA/00000492/202506
PSUSA/00000592/202503
Submitted by Anonymous (not verified) on 15 January 2026 - 14:53
PSUSA/00000592/202503
EMEA-003402-PIP01-23
Submitted by Anonymous (not verified) on 15 January 2026 - 14:45
EMEA-003402-PIP01-23
Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 19, Status: Authorised
Submitted by Anonymous (not verified) on 15 January 2026 - 14:42
Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 19, Status: Authorised
Q&A Clinic - New Variation Classification in eAF , Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 January 2026, 10:00 (CET) to 8 January 2026, 11:00 (CET)
Submitted by Anonymous (not verified) on 15 January 2026 - 14:38
Q&A Clinic - New Variation Classification in eAF , Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 January 2026, 10:00 (CET) to 8 January 2026, 11:00 (CET)
Human medicines European public assessment report (EPAR): Verkazia, ciclosporin, Date of authorisation: 06/07/2018, Revision: 8, Status: Authorised
Submitted by Anonymous (not verified) on 15 January 2026 - 14:35
Human medicines European public assessment report (EPAR): Verkazia, ciclosporin, Date of authorisation: 06/07/2018, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Ikervis, ciclosporin, Date of authorisation: 19/03/2015, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 15 January 2026 - 14:30
Human medicines European public assessment report (EPAR): Ikervis, ciclosporin, Date of authorisation: 19/03/2015, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Rhokiinsa, netarsudil, Date of authorisation: 19/11/2019, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 15 January 2026 - 14:14
Human medicines European public assessment report (EPAR): Rhokiinsa, netarsudil, Date of authorisation: 19/11/2019, Revision: 7, Status: Authorised